Media thread, page-415

Thanks for posting. That was a far less conservative speech and presentation by PA. I like it.

Calling $50 million yearly Striate wholesale revenue alone as Henry Schein rotates use from the old product to Striate. That's a rather large and forthright guidance call and very much above most expectations I am sure.

Remplir US mkt entry I was calling/hoping late 2024 with 2Q CY24 registration study results, but will take 1Q CY25.

$250 million yearly wholesale revenue call from Remplir at 20% of market another big guidance call. I like it. I'd settle for $100 million a year and $50 millioin from Striate.

I've been banging on for over a year now has this company is easily funded to Remplir entry (which the company affirms in its slides) and has indeed already shown outside of R&D to get ATI and Remplir to market, is already operationally cash flow positive. Market/investors missing a beat here....